Healthcare Triangle, Inc.
$2.47
▼
-2.76%
2026-04-21 07:16:00
www.healthcaretriangle.com
NCM: HCTI
Explore Healthcare Triangle, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.86 M
Current Price
$2.47
52W High / Low
$7,470 / $2.24
Stock P/E
—
Book Value
$17.67
Dividend Yield
—
ROCE
89.58%
ROE
-1.83%
Face Value
—
EPS
$-85.35
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
59
Beta
1.16
Debt / Equity
17.53
Current Ratio
2.03
Quick Ratio
0.21
Forward P/E
-0.08
Price / Sales
0.21
Enterprise Value
$7.61 M
EV / EBITDA
-1.29
EV / Revenue
0.59
Rating
None
Target Price
$300
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Balance sheet leverage appears manageable.
- Valuation is not stretched on P/E basis.
Cons
- Current ratio suggests tighter short-term liquidity.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Omada Health, Inc. | $14.04 | — | $827.31 M | — | -5.21% | -8.68% | $28.4 / $10.28 | $3.93 |
| 2. | Doximity, Inc. | $24.39 | 19.07 | $4.56 B | — | 20.77% | 23.82% | $76.51 / $20.55 | $5.29 |
| 3. | Veeva Systems Inc. | $165.91 | 30.52 | $27.21 B | — | 12.48% | 13.93% | $310.5 / $148.05 | $44.05 |
| 4. | Definitive Healthcare Corp. | $1.05 | — | $147.1 M | — | -3.56% | -40.42% | $4.7 / $0.92 | $2.7 |
| 5. | Zhongchao Inc. | $2.06 | — | $7.52 M | — | -1.4% | -24.88% | $12.18 / $1.44 | $6.39 |
| 6. | GoodRx Holdings, Inc. | $2.37 | 26.67 | $811.9 M | — | 7.56% | 4.54% | $5.81 / $1.77 | $1.81 |
| 7. | CareCloud, Inc. | $3.2 | 12.59 | $135.98 M | 4.63% | 18.2% | 19.76% | $4.01 / $1.33 | $1.4 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 3.49 M | 3.56 M | 3.7 M | 2.19 M | 2.41 M |
| Operating Profit | -2.59 M | -1.36 M | -1.4 M | -0.33 M | -1.17 M |
| Net Profit | -1.91 M | -1.37 M | -1.7 M | -1.35 M | -1.25 M |
| EPS in Rs | -1.65 | -1.18 | -1.47 | -1.17 | -1.08 |
Profit & Loss
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Sales | 11.7 M | 33.2 M | 45.89 M | 35.27 M |
| Operating Profit | -4.58 M | -5.99 M | -11.96 M | -5.36 M |
| Net Profit | -5.97 M | -8.69 M | -14.36 M | -5.95 M |
| EPS in Rs | -5.17 | -7.52 | -12.43 | -5.15 |
Balance Sheet
Figures shown in M / B
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Total Assets | 1.96 M | 6.86 M | 13.26 M | 24.61 M |
| Total Liabilities | 7.08 M | 8.25 M | 7.22 M | 8.48 M |
| Equity | -5.11 M | -1.39 M | 6.04 M | 16.14 M |
| Current Assets | 1.45 M | 5.65 M | 8.02 M | 11.8 M |
| Current Liabilities | 7.08 M | 8.15 M | 6.6 M | 6.25 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -1.08 M | -2.15 M | -5.35 M | -7.11 M |
| Investing CF | 0 M | -0.01 M | -1.13 M | -7.63 M |
| Financing CF | -0.13 M | 2.06 M | 6.06 M | 15.11 M |
| Free CF | -1.08 M | -2.16 M | -6.49 M | -10.24 M |
| Capex | — | -0.01 M | -1.13 M | -3.13 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | -64.77% | -27.64% | 30.1% | — |
| Earnings Growth % | 31.28% | 39.5% | -141.35% | — |
| Profit Margin % | -51.03% | -26.16% | -31.29% | -16.87% |
| Operating Margin % | -39.17% | -18.03% | -26.06% | -15.19% |
| Gross Margin % | 24.71% | 20.41% | 24.62% | 29.83% |
| EBITDA Margin % | -32.96% | -18.42% | -23.31% | -11.16% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
| Date | Split |
|---|---|
| 2026-02-10 | 1:0.0166667 |
| 2025-08-01 | 1:0.00401606 |
| 2023-05-26 | 1:0.1 |